85 related articles for article (PubMed ID: 16320839)
1. [ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque].
Zaslavskaia RM; Shcherban' EA; Logvinenko SI
Klin Med (Mosk); 2005; 83(10):19-21. PubMed ID: 16320839
[TBL] [Abstract][Full Text] [Related]
2. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
Demchenko EA; Berezina AV; Panov AV
Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
[No Abstract] [Full Text] [Related]
3. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
4. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
5. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
[No Abstract] [Full Text] [Related]
6. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Demin AA; Aksenova EA
Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of different methods of treatment of patients with stable stenocardia combined with arterial hypertension according to echocardiographic data].
Zaslavskaia RM; Shcherbakov EA; Logvinenko SI
Klin Med (Mosk); 2007; 85(8):40-3. PubMed ID: 17926489
[TBL] [Abstract][Full Text] [Related]
8. [Administration of various dosages of retard isosorbide-5-mononitrate in patients with stable angina pectoris on combined therapy].
Chernova EV; Kuchinskaia NG; Barysheva OV; Bezborodova IuV; Shatukhina EIu; Aleshin OI
Klin Med (Mosk); 2002; 80(1):55-7. PubMed ID: 11855323
[TBL] [Abstract][Full Text] [Related]
9. Differences in ischemic threshold and nitrate efficacy between normotensive and hypertensive patients with stable angina pectoris.
Marmor A; Reizin L; Caspi A; Botvin S; Schneeweiss A
Hypertens Res; 1995 Jun; 18(2):119-24. PubMed ID: 7584917
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis.
Jansen R; Niemeyer MG; Cleophas TJ; Zwinderman AH
Angiology; 2000 Dec; 51(12):1007-12. PubMed ID: 11132992
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
12. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
13. [Time-dependent hemodynamic effects of monosan (Isosorbide-5-mononitrate) in anginal patients].
Zholdin BK; Zaslavskaia RM; Zhamankulov KA
Klin Med (Mosk); 1998; 76(4):30-2. PubMed ID: 9613078
[TBL] [Abstract][Full Text] [Related]
14. [Antianginal effectiveness of regular isosorbide-5-mononitrate (monochinkwe retard) intake].
Golikov AP; Allenova IB; El'kina NS
Ter Arkh; 1999; 71(12):52-3. PubMed ID: 10647204
[No Abstract] [Full Text] [Related]
15. [Characteristics of the blood oxygen transport function in patients with angina pectoris receiving treatment correcting the L-arginine-NO pathway].
Zinchuk VV; Dobrodeĭ MA; Lis MA
Fiziol Cheloveka; 2008; 34(2):136-8. PubMed ID: 18472585
[No Abstract] [Full Text] [Related]
16. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
17. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
Kośmicki MA; Szwed H; Sadowski Z
Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
[TBL] [Abstract][Full Text] [Related]
18. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
[TBL] [Abstract][Full Text] [Related]
20. [Nitrates in therapy of effort angina in hypotensive patients].
Idrisova EM; Borovkova NV; Kladieva EA; Chernov VI; Demochko AV; Shishkina AA; Vorob'eva EV; Karpov RS
Klin Med (Mosk); 2003; 81(11):54-8. PubMed ID: 14689713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
